Document is current
Any future updates will be listed below
-
Authors
Moon, Seonyun
Smanski, Michael J
-
Funding
Funding for this research was provided by:
National Institutes of Health, USA (9R42AG083665, 9R42AG083665)
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 19 August 2025
First Online: 2 October 2025
Declarations
:
: not applicable
: not applicable
: MJS holds equity in BioSynthetics Inc., which is partially owned by MetSelex Inc., and was established to produce or license the biomanufacturing of TUDCA in yeast. This interest has been reviewed and managed by the University of Minnesota in accordance with its Conflict of interest policies.
